ALCON FDA Approval NDA 020619

NDA 020619

ALCON

FDA Drug Application

Application #020619

Application Sponsors

NDA 020619ALCON

Marketing Status

Discontinued001

Application Products

001SUSPENSION/DROPS;OPHTHALMICEQ 0.25% BASE;1.75%0BETOPTIC PILOBETAXOLOL HYDROCHLORIDE; PILOCARPINE HYDROCHLORIDE

FDA Submissions

TYPE 4; Type 4 - New CombinationORIG1AP1997-04-17STANDARD

CDER Filings

ALCON
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 20619
            [companyName] => ALCON
            [docInserts] => ["",""]
            [products] => [{"drugName":"BETOPTIC PILO","activeIngredients":"BETAXOLOL HYDROCHLORIDE; PILOCARPINE HYDROCHLORIDE","strength":"EQ 0.25% BASE;1.75%","dosageForm":"SUSPENSION\/DROPS;OPHTHALMIC","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"BETOPTIC PILO","submission":"BETAXOLOL HYDROCHLORIDE; PILOCARPINE HYDROCHLORIDE","actionType":"EQ 0.25% BASE;1.75%","submissionClassification":"SUSPENSION\/DROPS;OPHTHALMIC","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.